Glycogen storage disease type VI: clinical course and molecular background

被引:19
作者
Aeppli, Tim R. J. [1 ]
Rymen, Daisy [2 ,3 ]
Allegri, Gabriella [2 ,3 ]
Bode, Peter K. [4 ]
Haeberle, Johannes [2 ,3 ]
机构
[1] Univ Childrens Hosp Zurich, Div Endocrinol & Diabetol, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[3] Univ Childrens Hosp Zurich, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland
[4] Univ Hosp Zurich, Inst Pathol, Ramistr 100, CH-8091 Zurich, Switzerland
关键词
Glycogen storage disease type VI; Long-term outcome; Hypertriglyceridemia; Molecular genetic background; Phosphorylase; DIETARY-MANAGEMENT; PHOSPHORYLASE GENE; NATURAL-HISTORY; DEFICIENCY; MUTATIONS; DIAGNOSIS;
D O I
10.1007/s00431-019-03499-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Glycogen storage disease type VI (GSD-VI; also known as Hers disease, liver phosphorylase deficiency) is caused by mutations in the gene coding for glycogen phosphorylase (PYGL) leading to a defect in the degradation of glycogen. Since there are only about 40 patients described in literature, our knowledge about the course of the disease is limited. In order to evaluate the long-term outcome of patients with GSD-VI, an observational retrospective case study of six patients was performed at the University Children's Hospital Zurich. The introduction of small, frequent meals as well as cornstarch has led to normal growth in all patients and to normalization of liver transaminases in most patients. After starting the dietary regimen, there were no signs of hypoglycemia. However, three of six patients showed persistent elevation of triglycerides. Further, we identified four novel pathogenic PYGL mutations and describe here their highly variable impact on phosphorylase function. Conclusions: After establishing the diagnosis, dietary treatment led to metabolic stability and to prevention of hypoglycemia. Molecular genetics added important information for the understanding of the clinical variability in this disease. While outcome was overall excellent in all patients, half of the patients showed persistent hypertriglyceridemia even after initiating treatment.What is Known:center dot Glycogen storage disease type VI (GSD-VI) is a metabolic disorder causing a defect in glycogen degradation. Dietary treatment normally leads to metabolic stability and prevention of hypoglycemia.center dot However, our knowledge about the natural course of patients with GSD-VI is limited.What is New:center dot While outcome was overall excellent in all patients, half of the patients showed persistent hypertriglyceridemia even after initiating treatment.center dot Molecular genetics added important information for the understanding of the clinical variability in this disease.
引用
收藏
页码:405 / 413
页数:9
相关论文
共 28 条
[1]   THE ALLOSTERIC TRANSITION OF GLYCOGEN-PHOSPHORYLASE [J].
BARFORD, D ;
JOHNSON, LN .
NATURE, 1989, 340 (6235) :609-616
[2]   High frequency of missense mutations in glycogen storage disease type VI [J].
Beauchamp, N. J. ;
Taybert, J. ;
Champion, M. P. ;
Layet, V. ;
Heinz-Erian, P. ;
Dalton, A. ;
Tanner, M. S. ;
Pronicka, E. ;
Sharrard, M. J. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (05) :722-734
[3]   Structural relationships among regulated and unregulated phosphorylases [J].
Buchbinder, JL ;
Rath, VL ;
Fletterick, RJ .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2001, 30 :191-209
[4]   Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI (Hers disease) [J].
Burwinkel, B ;
Bakker, HD ;
Herschkovitz, E ;
Moses, SW ;
Shin, YS ;
Kilimann, MW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (04) :785-791
[5]   Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI [J].
Chang, S ;
Rosenberg, MJ ;
Morton, H ;
Francomano, CA ;
Biesecker, LG .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :865-870
[6]  
Dagli A., 1993, Glycogen Storage Disease Type III
[7]   Liver glycogen storage diseases due to phosphorylase system deficiencies: Diagnosis thanks to non invasive blood enzymatic and molecular studies [J].
Davit-Spraul, Anne ;
Piraud, Monique ;
Dobbelaere, Dries ;
Valayannopoulos, Vassili ;
Labrune, Philippe ;
Habes, Dalila ;
Bernard, Olivier ;
Jacquemin, Emmanuel ;
Baussan, Christiane .
MOLECULAR GENETICS AND METABOLISM, 2011, 104 (1-2) :137-143
[8]   Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions [J].
Derks, Terry G. J. ;
van Rijn, Margreet .
JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (03) :537-543
[9]   Dietary management in glycogen storage disease type III: what is the evidence? [J].
Derks, Terry G. J. ;
Smit, G. Peter A. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (03) :545-550
[10]  
Elpeleg ON, 1999, J PEDIATR ENDOCR MET, V12, P363